Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The European Venous Registry (EVeR) is a project aimed at collecting information about treatments and results for people with deep venous disease in the lower limbs. This condition affects the veins in the legs and can lead to serious problems if not treated properly. The registry will gather data over ten years to help doctors understand which treatments work best and to improve patient care based on scientific evidence.
To participate in this study, individuals aged 65 to 74 with a confirmed diagnosis of either acute or chronic deep venous disease in the legs are eligible, as long as they agree to join the registry. However, those who cannot give consent, have certain specific conditions like upper limb blood clots, or are under 18 years old, will not be included. Participants can expect to share their treatment experiences and outcomes, which will contribute to a better understanding of this disease for future patients. The registry is not currently recruiting participants, but it will play an important role in enhancing treatment strategies for deep venous disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with an imaging-confirmed new diagnosis of acute or chronic lower limb deep venous disease involving the iliac and/or common femoral veins, with or without extension to the inferior vena cava, or patients with an imaging-confirmed new diagnosis involving the IVC only.
- • Consent to enter registry.
- Exclusion Criteria:
- • Unable to consent to enter into registry.
- • Isolated upper limb DVT.
- • Central venous thrombosis (e.g. superior vena cava obstruction).
- • Isolated deep vein thrombosis below the common femoral vein.
- • Isolated superficial venous thrombosis.
- • Isolated superficial venous thrombophlebitis.
- • Isolated varicose veins.
- • Aged \<18 years.
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bristol, , United Kingdom
London, , United Kingdom
Milan, , Italy
Marseille, , France
Aachen Maastricht, , Germany
Athens, , Greece
Galway, , Ireland
Rotterdam, , Netherlands
Madrid, , Spain
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported